{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:55:16Z","timestamp":1782496516503,"version":"3.54.5"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>C5a and its receptor, C5aR, are involved in the degranulation of mast cells and basophils, leading to the release of proinflammatory cytokines. However, to date, their roles in the pathogenesis of chronic spontaneous urticaria (CSU) remain incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the association of plasma C5a and serum C5aR with disease severity in Vietnamese patients with CSU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A case-control study was conducted involving 146 patients with CSU and 30 healthy adults matched by age and sex (the matching ratio\u2009~\u20095:1), at the Urticaria clinic, National Hospital of Dermatology and Venereology, Vietnam. Plasma C5a and serum C5aR levels were measured using the ELISA technique, and disease severity was assessed using the Urticaria Activity Score over 7 days (UAS7). The associations between C5a\/C5aR with disease severity and several patient\u2019s characteristics were evaluated using Spearman\u2019s correlation and logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Plasma C5a levels were significantly increased in CSU patients compared to healthy controls (p\u2009&lt;\u20090.001), whereas serum C5aR levels in CSU patients were significantly reduced (p\u2009&lt;\u20090.001). A significant positive correlation was found between disease severity based on UAS7 scores and plasma C5a levels (Spearman\u2019s rho\u2009=\u20090.63, p\u2009&lt;\u20090.001), but not for serum C5aR levels (Spearman\u2019s rho\u2009=\u20090.05, p\u2009=\u20090.527). A C5a level of 4335 pg\/mL was defined as the optimal cutoff points for identifying severe CSU with an AUC of 0.86 (95% CI: 0.80\u20130.92, p\u2009&lt;\u20090.001), sensitivity of 64%, and specificity of 100%. Several factors were found to be associated with C5a and C5aR levels, such as prothrombin time and anti-TPO antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CSU patients demonstrate elevated plasma C5a and reduced serum C5aR levels compared to healthy controls. While plasma C5a may serve as a potential biomarker for indicating CSU severity, C5aR levels show no significant association with the disease severity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0351329","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:40:46Z","timestamp":1782495646000},"page":"e0351329","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma C5a and serum C5aR levels in patients with chronic spontaneous urticaria: A single-center case-control study"],"prefix":"10.1371","volume":"21","author":[{"given":"Thao T.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5025-0209","authenticated-orcid":true,"given":"Minh N.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My H.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doanh H.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2759-7113","authenticated-orcid":true,"given":"Thuong V.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-599X","authenticated-orcid":true,"given":"Phuong T.M.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"3","key":"pone.0351329.ref001","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA\u00b2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"T Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"pone.0351329.ref002","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/164_2021_506","article-title":"The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update","volume":"268","author":"M Maurer","year":"2022","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"pone.0351329.ref003","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-022-00389-z","article-title":"Urticaria","volume":"8","author":"P Kolkhir","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"pone.0351329.ref004","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/imr.12632","article-title":"The role and relevance of mast cells in urticaria","volume":"282","author":"MK Church","year":"2018","journal-title":"Immunol Rev"},{"issue":"6","key":"pone.0351329.ref005","doi-asserted-by":"crossref","first-page":"100533","DOI":"10.1016\/j.waojou.2021.100533","article-title":"The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management","volume":"14","author":"M S\u00e1nchez-Borges","year":"2021","journal-title":"World Allergy Organ J"},{"issue":"2","key":"pone.0351329.ref006","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/all.15603","article-title":"Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances","volume":"78","author":"A Kaplan","year":"2023","journal-title":"Allergy"},{"key":"pone.0351329.ref007","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fimmu.2019.00627","article-title":"Autoimmune Theories of Chronic Spontaneous Urticaria","volume":"10","author":"SJ Bracken","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"pone.0351329.ref008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria","volume":"134","author":"D Fujisawa","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"pone.0351329.ref009","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-021-00622-y","article-title":"Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases","volume":"22","author":"P Kolkhir","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"pone.0351329.ref010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaci.2006.08.043","article-title":"Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria","volume":"119","author":"R Asero","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"pone.0351329.ref011","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1346-8138.2008.00474.x","article-title":"Elevation of circulating thrombin-antithrombin III complex and fibrin degradation products in urticaria: a laboratory finding unrelated to intravascular coagulopathy","volume":"35","author":"K Fujii","year":"2008","journal-title":"J Dermatol"},{"key":"pone.0351329.ref012","article-title":"Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria","author":"H Zhu","year":"2023","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"7","key":"pone.0351329.ref013","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/cells10071759","article-title":"The Role of Coagulation and Complement Factors for Mast Cell Activation in the Pathogenesis of Chronic Spontaneous Urticaria","volume":"10","author":"Y Yanase","year":"2021","journal-title":"Cells"},{"issue":"9","key":"pone.0351329.ref014","first-page":"1283","article-title":"Activation of the Blood Coagulation System in Patients with Chronic Spontaneous Urticaria","volume":"61","author":"D Wang","year":"2015","journal-title":"Clin Lab"},{"issue":"2","key":"pone.0351329.ref015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.alit.2017.09.003","article-title":"Chronic spontaneous urticaria and the extrinsic coagulation system","volume":"67","author":"Y Yanase","year":"2018","journal-title":"Allergol Int"},{"issue":"3","key":"pone.0351329.ref016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.08.018","article-title":"Coagulation factors induce human skin mast cell and basophil degranulation via activation of complement 5 and the C5a receptor","volume":"147","author":"Y Yanase","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"pone.0351329.ref017","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12011","article-title":"Systemic and local evidence for complement involvement in chronic spontaneous urticaria","volume":"11","author":"M Alizadeh Aghdam","year":"2021","journal-title":"Clin Transl Allergy"},{"issue":"1","key":"pone.0351329.ref018","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5415\/apallergy.0000000000000132","article-title":"A prospective observational study correlating possible novel biomarkers with disease severity and antihistamine response in chronic spontaneous urticaria","volume":"14","author":"D Bhatia","year":"2024","journal-title":"Asia Pac Allergy"},{"issue":"12","key":"pone.0351329.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189017","article-title":"C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid","volume":"12","author":"L Hornum","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"pone.0351329.ref020","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jaci.2005.01.068","article-title":"Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma","volume":"115","author":"L Fregonese","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"pone.0351329.ref021","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/sj.jid.5700416","article-title":"Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a","volume":"126","author":"R Gutzmer","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"1","key":"pone.0351329.ref022","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI0215409","article-title":"Increased C5a receptor expression in sepsis","volume":"110","author":"NC Riedemann","year":"2002","journal-title":"J Clin Invest"},{"issue":"8","key":"pone.0351329.ref023","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.4049\/jimmunol.1200534","article-title":"Changes and regulation of the C5a receptor on neutrophils during septic shock in humans","volume":"190","author":"H Unnewehr","year":"2013","journal-title":"J Immunol"},{"key":"pone.0351329.ref024","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1242\/jcs.110.19.2381","article-title":"Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain","author":"N Naik","year":"1997","journal-title":"J Cell Sci"},{"issue":"4","key":"pone.0351329.ref025","doi-asserted-by":"crossref","DOI":"10.1186\/cc1524","article-title":"Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis","volume":"6","author":"M Furebring","year":"2002","journal-title":"Crit Care"},{"issue":"2","key":"pone.0351329.ref026","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5415\/apallergy.2013.3.2.100","article-title":"Correlation between plasma D-dimer levels and the severity of patients with chronic urticaria","volume":"3","author":"D Triwongwaranat","year":"2013","journal-title":"Asia Pac Allergy"},{"issue":"1","key":"pone.0351329.ref027","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000453453","article-title":"D-Dimer plasma levels parallel the clinical response to omalizumab in patients with severe chronic spontaneous urticaria","volume":"172","author":"R Asero","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"issue":"12","key":"pone.0351329.ref028","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1111\/all.13936","article-title":"Baseline D-dimer plasma levels correlate with disease activity but not with the response to omalizumab in chronic spontaneous urticaria","volume":"74","author":"R Asero","year":"2019","journal-title":"Allergy"},{"issue":"5","key":"pone.0351329.ref029","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4103\/idoj.IDOJ_106_21","article-title":"Causal relationship between D-Dimers and disease status in chronic spontaneous urticaria and adjuvant effect of oral tranexamic acid","volume":"12","author":"G Dabas","year":"2021","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"pone.0351329.ref030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000292947","article-title":"Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study","volume":"152","author":"R Asero","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"issue":"8","key":"pone.0351329.ref031","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1365-2222.2000.00857.x","article-title":"Warfarin treatment of chronic idiopathic urticaria and angio-oedema","volume":"30","author":"R Parslew","year":"2000","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"pone.0351329.ref032","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/all.14110","article-title":"Increase of tissue factor expression on the surface of peripheral monocytes of patients with chronic spontaneous urticaria","volume":"75","author":"R Saito","year":"2020","journal-title":"Allergy"},{"issue":"1","key":"pone.0351329.ref033","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jdv.70027","article-title":"Sex matters in CSU: Women face greater burden and poorer urticaria control, especially in midlife-CURE insights","volume":"40","author":"E Kocat\u00fcrk","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:40:52Z","timestamp":1782495652000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351329"}},"subtitle":[],"editor":[{"given":"Cheorl-Ho","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0351329","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}